Latest Articles
- Alpha-blockers and congestive heart failure: Early termination of an arm of the ALLHAT trial
Current guidelines for treating high blood pressure need to be changed, in light of surprising findings from a major study.
- ‘Interpreting Key Trials’: Doing what we do best
A key CCJM mission is to quickly translate the results of important trials into practical clinical advice.
- Effective treatment of Alzheimer disease and its complications
Prompt and careful treatment can improve the quality of life for Alzheimer patients.
- Cancer genetics for the clinician: Recommendations on screening for BRCA1 and BRCA2 mutations
The discovery of cancer-related genes raises difficult questions for clinicians and patients.
How should patients taking the discontinued diabetes drug troglitazone be managed?The newer insulin sensitizers appear safe, but monitoring for hepatotoxicity is still warranted.
- Appropriate use of DNR orders: A practical approach
A procedure and rationale for resolving conflict and reaching consensus about end-of-life care.
